Health Care: Drugs

Hemispherx Biopharma Inc. (HEB: AMEX)

$0.3185 -0.0068 | -2.09%
04/17/14 - 03:22 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 213.00K 161.00K 135.00K 111.00K
Cost of Sales 1.31M 413.00K 561.00K 584.00K
Gross Operating Profit -1.09M -252.00K -426.00K -473.00K
Selling, General, and Administrative Expenses 9.06M 6.69M 7.57M 5.80M
Research & Development 9.51M 6.72M 7.61M 7.00M
Operating Income before D & A (EBITDA) -19.66M -13.66M -15.61M -13.26M
Depreciation & Amortization 683.00K 630.00K 780.00K 981.00K
Interest Income 1.60M 624.00K 2.38M 67.00K
Other Income - Net 1.41M 4.70M 879.00K 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -17.33M -8.97M -13.12M -14.18M
Interest Expense 24.00K 41.00K 11.00K 241.00K
Pre-Tax Income -17.35M -9.02M -13.14M -14.42M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -17.35M -9.02M -13.14M -13.44M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -17.35M -9.02M -13.14M -13.44M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -17.35M -9.02M -13.14M -13.44M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-17.35M -9.02M -13.14M -13.44M
Preferred Dividends
Net Income Available To Common -17.35M -9.02M -13.14M -13.44M
Basic EPS from Continuing Ops. -0.12 -0.07 -0.10 -0.12
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.12 -0.07 -0.10 -0.12
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.12 -0.07 -0.10 -0.12
Basic Normalized Net Income/Share -0.12 -0.07 -0.10 -0.12
EPS fr Continuing Ops. -0.12 -0.07 -0.10 -0.12
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.12 -0.07 -0.10 -0.12
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.12 -0.07 -0.10 -0.12
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.12 -0.07 -0.10 -0.12
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with HEB

Latest HEB Headlines from TheStreet

More Financial News for HEB

Press Releases for HEB

See All Press Releases

Partner Headlines for HEB

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter